Active, Not Recruiting
SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma
NCT03546582
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Cleveland Clinic - Weston Weston, Florida, United States
- University of Louisville, James Graham Brown Cancer Center Louisville, Kentucky, United States